The Efficacy and Tolerability of Pegylated Interferon-α-2a in Chronic Hepatitis B: A Multicenter Clinical Experience
Journal of Gastroenterology and Hepatology,

Ratnam D et al. – In everyday clinical practice Pegylated Interferon–α (PEG–IFN) therapy in chronic Hepatitis B (CHB) is well tolerated and can achieve a similar efficacy to that seen in large controlled trials.

Please login or register to follow this author.
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

    Currently, there are no available articles.

Your Unread Messages in Family Medicine

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Family Medicine Articles

Indexed Journals in Family Medicine: American Family Physician, Archives of Family Med, Annals of Family Medmore